Lynch Alissa Hsu
Lynch Alissa Hsu's purchase track record
Lynch Alissa Hsu has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 11/29/2022 | LUNG | $9K | +110.3% | +115.5% | +6.3% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
Pulmonx Sets Q3 2026 Earnings Date for October 27. Pulmonx Corporation has announced that it will report its third-quarter 2026 financial results on October 27, 2026. This scheduled update provides a specific timeline for investors to review the company's latest performance metrics. The announcement serves as a standard corporate disclosure rather than a change in business operations.
Transaction History
| HNST | ▲ Buy | Grant | 41,970 | $0 | 5/21/2026 | View on chart |
| HNST | ▲ Buy | Grant | 38,252 | $0 | 5/28/2025 | View on chart |
| HNST | ▲ Buy | Grant | 9,348 | $70K | 1/1/2025 | View on chart |
| HNST | ▲ Buy | Grant | 60,569 | $0 | 5/22/2024 | View on chart |
| HNST | ▲ Buy | Grant | 51,659 | $0 | 12/8/2023 | View on chart |
| HNST | ▲ Buy | Grant | 112,908 | $0 | 12/8/2023 | View on chart |
| LUNG | ▲ Buy | Grant | 12,620 | $0 | 6/1/2023 | View on chart |
| LUNG | ▲ Buy | Open Market | 1,700 | $9K | 11/29/2022 | View on chart |
| LUNG | ▲ Buy | Grant | 5,600 | $0 | 6/1/2022 | View on chart |
| LUNG | ▲ Buy | Grant | 4,610 | $0 | 9/1/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 25, 2026
HNST: Earnings improve but business outlook remains uncertain
A recent Seeking Alpha article notes that The Honest Company posted better-than-expected earnings, showing improvement in revenue and margins. However, the piece also points to ongoing questions about the durability of its business model and growth prospects. The commentary comes as the stock trades near its long‑standing support level of $2.70.
HNST: Earnings improve but business outlook remains uncertain. A recent Seeking Alpha article notes that The Honest Company posted better-than-expected earnings, showing improvement in revenue and margins. However, the piece also points to ongoing questions about the durability of its business model and growth prospects. The commentary comes as the stock trades near its long‑standing support level of $2.70.